DarioHealth Corp. (DRIO)

Market Cap	31.13M
Revenue (ttm)	28.03M
Net Income (ttm)	-29.97M
Shares Out	44.46M
EPS (ttm)	-0.57
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	65,780
Open	0.7188
Previous Close	0.7000
Day's Range	0.6750 - 0.7188
52-Week Range	0.5011 - 1.5500
Beta	1.55
Analysts	Strong Buy
Price Target	2.50 (+257.04%)
Earnings Date	Aug 7, 2025

About DRIO

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral heal...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2011
• Employees: 202
• Stock Exchange: NASDAQ
• Ticker Symbol: DRIO
• Website: https://www.dariohealth.com

Financial Performance

In 2024, DarioHealth's revenue was $27.04 million, an increase of 32.86% compared to the previous year's $20.35 million. Losses were -$30.09 million, -45.15% less than in 2023.

Analyst Summary

According to 2 analysts, the average rating for DRIO stock is "Strong Buy." The 12-month stock price target is $2.5, which is an increase of 257.04% from the latest price.

Price Target

$2.5

(257.04% upside)

Analyst Consensus: Strong Buy